PRAME and HLA Typing: Practical Guidance for Melanoma Care
PRAME expression can signal metastatic risk in uveal melanoma, while HLA restriction may determine access to vaccines, engineered T-cell therapies and bispecific agents.
Topic
Topic
PRAME expression can signal metastatic risk in uveal melanoma, while HLA restriction may determine access to vaccines, engineered T-cell therapies and bispecific agents.